INmune Bio, Inc.

NASDAQ:INMB

2.31 (USD) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015
Revenue 0.0140.1550.3740.1810.01100000
Cost of Revenue 0000000000
Gross Profit 0.0140.1550.3740.1810.01177.6880000
Gross Profit Ratio 1111100000
Reseach & Development Expenses 33.16620.27317.06720.5435.9173.2821.1050.4350.1010
General & Administrative Expenses 9.4839.6239.2588.7916.3216.01611.3350.5460.1260.195
Selling & Marketing Expenses 00000.0520.0330000
SG&A 9.4839.6239.2588.7916.3216.0169.0850.5460.1260.049
Other Expenses 00-1.348-1.1870-1.5420-000
Operating Expenses 42.64929.89626.32529.33412.2397.75612.440.9810.2270.049
Operating Income -42.635-29.741-25.951-29.153-12.228-7.756-12.44-0.981-0.227-0.049
Operating Income Ratio -3,045.357-191.877-69.388-161.066-1,120.19100000
Total Other Income Expenses Net 0.553-0.267-1.348-1.1870.1290.07800.15-0.050
Income Before Tax -42.082-30.008-27.299-30.34-12.099-7.678-12.44-0.831-0.277-0.049
Income Before Tax Ratio -3,005.857-193.6-72.992-167.624-1,108.38800000
Income Tax Expense 001.348-29.153-12.2281.464-0.161-1.131-0.1770
Net Income -42.082-30.008-27.299-30.34-12.099-7.678-12.44-0.831-0.277-0.049
Net Income Ratio -3,005.857-193.6-72.992-167.624-1,108.37300000
EPS -2.08-1.67-1.52-1.88-1.01-0.89-1.11-0.074-0.025-0.004
EPS Diluted -2.08-1.67-1.52-1.88-1.01-0.89-1.11-0.074-0.025-0.004
EBITDA -42.082-29.741-25.951-29.153-12.228000.15-0.050.147
EBITDA Ratio -3,005.857-191.877-69.388-161.066-1,120.19100000